Substrate
Topic

GLP-1 medications

1 stories related to this topic, newest first.

French Regulator Fines Novo Nordisk and Eli Lilly for Weight Loss Drug Advertising Violationsnews18.com
finance21 hrs agoDeveloping

French Regulator Fines Novo Nordisk and Eli Lilly for Weight Loss Drug Advertising Violations

France's medicines regulator imposed fines on Novo Nordisk and Eli Lilly for misleading advertisements related to their weight loss drugs. The penalties come amid launches of oral GLP-1 medications in the U.S., with Novo Nordisk's Wegovy pill gaining early traction. Company execu…

cnbc.com
Stat
2 sources